Cimzia
Active substance: certolizumab pegol
certolizumab pegol
Centralised EU authorisationActive
Marketing holder: UCB Pharma
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-615a-7eef-8d0f-b6ce33a40398,01a12098-bdb2-746b-9393-ab0e4a9a4f5f,01a1209b-118f-7b41-8d0e-5f36c8cedbc0;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/001037
- Registration status
- Active
- ATC code
- L04AB05
Sources
- product · EMA · EMEA/H/C/001037 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001037 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001037 · Verified 2026-10-09